Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2000
10/05/2000CA2368467A1 50 human secreted proteins
10/05/2000CA2368455A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
10/05/2000CA2368302A1 49 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2367766A1 Retro-inverso prosaposin-derived peptides and use thereof
10/05/2000CA2366305A1 Method for expressing proteins
10/05/2000CA2365401A1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
10/05/2000CA2361016A1 Diaryl derivatives and their use as medicaments
10/04/2000EP1041072A1 Dioxocyclopentyl hydroxamic acids
10/04/2000EP1041068A1 Compounds for treating and preventing diabetic complications
10/04/2000EP1041064A2 N-substituted alpha aminoacid amides as calcium channel modulators
10/04/2000EP1040194A1 Human signal transduction serine/threonine kinase
10/04/2000EP1040185A2 Neural precursor cells, method for the production and use thereof in neural defect therapy
10/04/2000EP1040122A1 Protein binding polypeptides
10/04/2000EP1040117A1 110 human secreted proteins
10/04/2000EP1040101A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
10/04/2000EP1040099A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals
10/04/2000EP1040097A1 Potassium channel openers
10/04/2000EP1040096A1 Neuroprotective agents
10/04/2000EP1039929A1 Activated t-cells and their uses
10/04/2000EP1039923A1 Gamma-conopeptides
10/04/2000EP1039919A1 Composition for improving mental capabilities in mammals
10/04/2000EP1039903A1 Il-8 receptor antagonists
10/04/2000EP1039901A1 Treatment for alzheimer's disease
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000EP1039802A1 Transdermal therapeutic device and method with capsaicin and capsaicin analogs
10/04/2000EP1019040A4 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
10/04/2000EP0802901B1 Novel carbamate compounds containing thiocarbamoyl group and process for preparing the same
10/04/2000EP0772610B1 Dihydrobenzofuranes
10/04/2000EP0765311B1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
10/04/2000EP0699236B1 Purified mammalian flt3 ligands and agonists and antagonists thereof
10/04/2000EP0690719B1 Dry mix formulation for bisphosphonic acids
10/04/2000CN1268973A Beta-amyloid peptdie-binding proteins and polynucleotides encoding the same
10/04/2000CN1268949A Fused thiophene compounds and medical use thereof
10/04/2000CN1268938A Aminocycloalkane compounds
10/04/2000CN1268890A Sustained release tablet formulations to treat Parkinson disease
10/04/2000CN1268889A Novel process for obtg. intermediates
10/04/2000CN1268361A Pure Chinese herb medicine for stopping drugs
10/04/2000CN1268352A Method for preparing medicinal prepns. contg. 6-heterocycle-4-amino-1,3,4,5-tetrabenzo [cd] indole
10/04/2000CN1057088C Benzimidazole, prepn. method and use thereof
10/04/2000CN1057083C Tricyclic 1-aminoethylpyrrol derivative
10/04/2000CN1057013C Novel 1 L-2 receptor-specific human immunoglobins
10/04/2000CN1057003C Application of theaflavine for prepn. of medicine for treating cerebral senilism and dementia
10/03/2000US6127681 Scanning tunnel microscope
10/03/2000US6127522 CRFG-1a, a target and marker for chronic renal failure
10/03/2000US6127427 Active hydroxamic acids involved in tissue degradtion and also are inhibitors of the release of tumour necrosis factor from cells; rheumatoid arthritis, osteoarthritis, osteopenias such as osteoporosis, periodontitis, vision defects
10/03/2000US6127423 Phenylamidine derivatives, a process for preparing the same and their use as medicaments
10/03/2000US6127414 Antagonists of neuropeptide y and, in particular, in the treatment of cardiovascular diseases, e.g., vasoconstriction; hypotensive agents
10/03/2000US6127412 Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
10/03/2000US6127408 Thioether furan nitrone compounds; nervous system degenerative disorders, e.g. alzheimer's disease; analysis of free radicals by forming adducts; inhibit the forming of a beta(1-42) beta-pleated sheets and/or suppressing cytokines
10/03/2000US6127401 Treatment of prostate disorders, angiogenic disorders, neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease
10/03/2000US6127399 Certain pyrazole derivatives as cortiocotropin-releasing factor receptor CRF1 specific ligands
10/03/2000US6127396 Imidazoline compounds
10/03/2000US6127388 Azetidine, pyrrolidine and piperidine derivatives as 5-HT1D receptor agonists
10/03/2000US6127386 Stimulants, neurotransmitters, cholinergic agents
10/03/2000US6127382 An antiproliferative agent for treating skin-related diseases, an antitumor agent treating cancer, an antiinflammatory agent treating pulmonary fibrosis, ileitis, colitis and krohn's disease
10/03/2000US6127373 Method of treating tourette's syndrome and obsessive compulsive disorder
10/03/2000US6127370 Method for treating alzheimer's disease
10/03/2000US6127368 Anellated β-carbolines
10/03/2000US6127367 Administering an aldose reductase inhibitor as an antiischemic agent
10/03/2000US6127365 Tachykinin antagonists for treatment of pain, inflammation, migraine, emesis and postherpetic neuralgia.
10/03/2000US6127362 9,10-diazatricyclo[4,4,1,12,5 ] decane and 2,7-diazatricyclo [4,4,0,03,8 ] decane derivatives having analgesic activity
10/03/2000US6127357 N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl)alkyl)-N-(N-heteroaryl)substituted carboxamides
10/03/2000US6127348 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/03/2000US6126969 Immediate release/sustained release compressed tablets
10/03/2000US6126968 Stable compositions containing N-propargyl-1-aminoindan
10/03/2000US6126956 Subcutaneous implant
10/03/2000US6126939 Anti-inflammatory dipeptide and pharmaceutical composition thereof
10/03/2000US6126932 Insoluble polymer bearing pendant side chains, said side chains each terminating with the 1-(3-(1-pyrrolidinyl)-propyl)-3-ethylcarbodiimide moiety.
10/03/2000CA2177773C New aryl(alkyl)propylamides, process for preparing the same and pharmaceutical compositions containing them
09/2000
09/28/2000WO2000057185A1 Method for detecting superantigen activity in a biological sample
09/28/2000WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000WO2000056891A2 Human transmembrane proteins
09/28/2000WO2000056890A1 Human fgf gene and gene expression products
09/28/2000WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000WO2000056886A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
09/28/2000WO2000056882A1 48 human secreted proteins
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056880A1 50 human secreted proteins
09/28/2000WO2000056871A2 CELLS COEXPRESSING AN AMYLOID PRECURSOR PROTEIN AND AN α-SECRETASE AND THEIR USES IN TEST METHODS AND DIAGNOSTICS
09/28/2000WO2000056862A1 Human tumor necrosis factor receptor tr9
09/28/2000WO2000056772A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000WO2000056771A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056765A1 48 human secreted proteins
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056754A1 48 human secreted proteins
09/28/2000WO2000056753A1 49 human secreted proteins
09/28/2000WO2000056752A2 Apoptosis related genes
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056738A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000WO2000056733A1 Triazolopyrimidinol compounds and salts thereof
09/28/2000WO2000056728A1 Tetrahydropyran derivatives and their use as therapeutic agents
09/28/2000WO2000056727A1 Tetrahydropyran derivatives and their use as therapeutic agents
09/28/2000WO2000056718A1 Imidazole compounds
09/28/2000WO2000056712A1 Sulfonamide derivatives as 5-ht7 receptor antagonists
09/28/2000WO2000056711A1 Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
09/28/2000WO2000056710A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
09/28/2000WO2000056704A1 Hydroxamic and carboxylic acid derivatives
09/28/2000WO2000056404A1 Formulations for treatment of pain comprising vitamin b12 and phenylanine
1 ... 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 ... 1833